DealsJeito Capital to sell EyeBiotech to Merck & Co for $3bnEyeBiotech is a clinical-stage ophthalmology biotechnology company.ByIrien Joseph29 May 2024•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareTMTBriefs